1. Home
  2. PD vs SPRY Comparison

PD vs SPRY Comparison

Compare PD & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PagerDuty Inc.

PD

PagerDuty Inc.

HOLD

Current Price

$8.84

Market Cap

782.0M

Sector

Technology

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$6.15

Market Cap

788.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PD
SPRY
Founded
2009
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
782.0M
788.5M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
PD
SPRY
Price
$8.84
$6.15
Analyst Decision
Buy
Strong Buy
Analyst Count
9
1
Target Price
$12.63
$40.00
AVG Volume (30 Days)
2.0M
1.9M
Earning Date
05-28-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
416.95
N/A
EPS
0.13
N/A
Revenue
$492,546,000.00
$84,278,000.00
Revenue This Year
$3.58
$87.40
Revenue Next Year
$2.88
$81.64
P/E Ratio
$72.23
N/A
Revenue Growth
5.36
N/A
52 Week Low
$5.70
$6.16
52 Week High
$17.45
$18.63

Technical Indicators

Market Signals
Indicator
PD
SPRY
Relative Strength Index (RSI) 40.33 26.30
Support Level $8.27 N/A
Resistance Level $9.35 $8.61
Average True Range (ATR) 0.61 0.46
MACD -0.19 -0.20
Stochastic Oscillator 0.40 3.84

Price Performance

Historical Comparison
PD
SPRY

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the company derives a majority of its revenue from the United States and the rest from International markets.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: